178 related articles for article (PubMed ID: 29414387)
81. Will the methamphetamine problem go away?
Rawson RA; Anglin MD; Ling W
J Addict Dis; 2002; 21(1):5-19. PubMed ID: 11831500
[TBL] [Abstract][Full Text] [Related]
82. Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine.
Tsui JI; Stephens D; Collins B; Denisiuk E; Hallgren KA; Blalock KL; Klein JW; Jack HE; Merrill JO
J Addict Med; 2023 Jul-Aug 01; 17(4):491-492. PubMed ID: 37579119
[No Abstract] [Full Text] [Related]
83. Reply to: "Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine".
Englander H
J Addict Med; 2023 Jul-Aug 01; 17(4):492-493. PubMed ID: 37579120
[No Abstract] [Full Text] [Related]
84. Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment.
Javdan NS; Ghoreishi FS; Sehat M; Ghaderi A; Banafshe HR
J Affect Disord; 2019 May; 251():235-241. PubMed ID: 30928863
[TBL] [Abstract][Full Text] [Related]
85. Pharmacological treatments of opiate dependence.
Benyamina A; Reynaud M; Blecha L; Karila L
Curr Pharm Des; 2011; 17(14):1384-8. PubMed ID: 21524267
[TBL] [Abstract][Full Text] [Related]
86. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
Margolin A; Avants SK; Kosten TR
J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
[TBL] [Abstract][Full Text] [Related]
87. [Bio-Psycho-Social Characteristics and Therapeutic Aspects of Methamphetamine-Dependent Women - Gender Specific Results of a Systematic Literature Search].
Neumann S; Soyka M; Franke AG
Psychother Psychosom Med Psychol; 2018 Jul; 68(7):281-289. PubMed ID: 28838011
[TBL] [Abstract][Full Text] [Related]
88. Stroke and methamphetamine use in young adults: a review.
Lappin JM; Darke S; Farrell M
J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1079-1091. PubMed ID: 28835475
[TBL] [Abstract][Full Text] [Related]
89. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.
Gonzales R; Ang A; Marinelli-Casey P; Glik DC; Iguchi MY; Rawson RA;
J Subst Abuse Treat; 2009 Dec; 37(4):353-61. PubMed ID: 19553066
[TBL] [Abstract][Full Text] [Related]
90. Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature.
Hersi M; Corace K; Hamel C; Esmaeilisaraji L; Rice D; Dryburgh N; Skidmore B; Garber G; Porath A; Willows M; MacPherson P; Sproule B; Flores-Aranda J; Dickey C; Hutton B
PLoS One; 2023; 18(10):e0292745. PubMed ID: 37819931
[TBL] [Abstract][Full Text] [Related]
91. The effect of methadone on depression among addicts: a systematic review and meta-analysis.
Mohammadi M; Kazeminia M; Abdoli N; Khaledipaveh B; Shohaimi S; Salari N; Hosseinian-Far M
Health Qual Life Outcomes; 2020 Nov; 18(1):373. PubMed ID: 33225933
[TBL] [Abstract][Full Text] [Related]
92. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
Leidl D; Takhar P; Li H
Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
[TBL] [Abstract][Full Text] [Related]
93. Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings.
Härtel-Petri R; Krampe-Scheidler A; Braunwarth WD; Havemann-Reinecke U; Jeschke P; Looser W; Mühlig S; Schäfer I; Scherbaum N; Bothe L; Schaefer C; Hamdorf W
Pharmacopsychiatry; 2017 May; 50(3):96-104. PubMed ID: 28445899
[TBL] [Abstract][Full Text] [Related]
94. Treatment of methamphetamine abuse: research findings and clinical directions.
Cretzmeyer M; Sarrazin MV; Huber DL; Block RI; Hall JA
J Subst Abuse Treat; 2003 Apr; 24(3):267-77. PubMed ID: 12810148
[TBL] [Abstract][Full Text] [Related]
95. Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents.
Embry D; Hankins M; Biglan A; Boles S
Addict Behav; 2009 Apr; 34(4):343-51. PubMed ID: 19138821
[TBL] [Abstract][Full Text] [Related]
96. Mental health correlates of drug treatment among women who use methamphetamine.
Rade CB; Desmarais SL; Van Dorn RA; Lutnick A; Kral AH; Lorvick J
Am J Addict; 2015 Oct; 24(7):646-53. PubMed ID: 26300389
[TBL] [Abstract][Full Text] [Related]
97. Changes in secondary outcomes associated with brief interventions for problem gambling in methadone patients.
Baxley C; Weinstock J; Rash CJ; Yalch MM; Borsari B; Garner AA; Benware J
Addict Behav; 2021 Sep; 120():106953. PubMed ID: 34022757
[TBL] [Abstract][Full Text] [Related]
98. Childhood adverse events and methamphetamine use among men and women.
Messina N; Marinelli-Casey P; Hillhouse M; Rawson R; Hunter J; Ang A
J Psychoactive Drugs; 2008 Nov; Suppl 5():399-409. PubMed ID: 19248397
[TBL] [Abstract][Full Text] [Related]
99. Gender differences in substance use patterns and disorders among an Iranian patient sample receiving methadone maintenance treatment.
Ghaderi A; Motmaen M; Abdi I; Rasouli-Azad M
Electron Physician; 2017 Sep; 9(9):5354-5362. PubMed ID: 29038721
[TBL] [Abstract][Full Text] [Related]
100. Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis.
Cumming C; Troeung L; Young JT; Kelty E; Preen DB
Drug Alcohol Depend; 2016 Nov; 168():263-273. PubMed ID: 27736680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
